Discovery may help scientists boost broccoli's cancer-fighting power

Key points
- A University of Illinois study has shown for the first time that sulforaphane, the powerful cancer-fighting agent in broccoli, can be released from its parent compound by bacteria in the lower gut and absorbed into the body.
- "This discovery raises the possibility that we will be able to enhance the activity of these bacteria in the colon, increasing broccoli's cancer-preventive power," said Elizabeth Jeffery, a U of I professor of human nutrition.
- "It's also comforting because many people overcook their broccoli, unwittingly destroying the plant enzyme that gives us sulforaphane.
- Although scientists had long theorized that the intestinal microbiota could perform this trick, no one knew it for certain.
A University of Illinois study has shown for the first time that sulforaphane, the powerful cancer-fighting agent in broccoli, can be released from its parent compound by bacteria in the lower gut and absorbed into the body.
"This discovery raises the possibility that we will be able to enhance the activity of these bacteria in the colon, increasing broccoli's cancer-preventive power," said Elizabeth Jeffery, a U of I professor of human nutrition.
"It's also comforting because many people overcook their broccoli, unwittingly destroying the plant enzyme that gives us sulforaphane. Now we know the microbiota in our digestive tract can salvage some of this important cancer-preventive agent even if that happens," she said.
Although scientists had long theorized that the intestinal microbiota could perform this trick, no one knew it for certain.
Now Jeffery and U of I colleagues Michael Miller and Ren-Hau Lai have proved it by injecting glucoraphanin, the parent compound for sulforaphane, into the ligated lower gut of rats and demonstrating that sulforaphane is present in blood from the mesenteric vein, which flows from the gut to the liver.
"The presence of sulforaphane in measurable amounts shows that it's being converted in the lower intestine and is available for absorption in the body," Jeffery said.
The cecum, the part of the rat's lower gut into which the scientists infused the glucoraphanin, houses bacteria that aid in digestion and metabolism, similar to the human colon.
According to Jeffery, sulforaphane is an extremely potent cancer-fighting agent. "The amount that you get in three to five servings a week—that's less than one daily serving of broccoli—is enough to have an anti-cancer effect. With many of the other bioactive foods you hear about, vast amounts are required for a measurable outcome."
Sulforaphane also has anti-inflammatory properties, which are interesting to scientists for their ability to counter the effects of many of the chronic diseases that accompany obesity and aging.
Miller suggests two ways bacteria in the colon could be manipulated to get a boost out of broccoli. "One way might be to feed the desirable bacteria with prebiotics like fiber to encourage their proliferation. Another way would be to use a probiotic approach—combining, say, broccoli with a yogurt sauce that contains the hydrolyzing bacteria, and in that way boosting your cancer protection."
Doesn't sound particularly appealing? Bacteria aren't always bad news, said Jeffery.
"One of the things we don't think about very much is the enormous amount of benefit we experience when a healthy community of bacteria colonizes the lower intestine," she said.
"We humans have a symbiotic relationship with countless hungry microbes that metabolize vitamins and other bioactive components of food. Now we can see another exciting example of their activity with the role they play in delivering sulforaphane from broccoli," she added.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBiomarker helps predict survival time in gastric cancer patients
Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality. A new study in The American Journal of Pathology points to a pivotal…
9 September 2015
NewsScientists discover cancer markers may be present early during human development
Researchers at the Virginia Bioinformatics Institute have uncovered a link between the genomes of cells originating in the neural crest and development of tumors -- a discovery that could lead to new ways to diagnose…
6 August 2015
NewsNew 'chemotherapy booster' could treat lung and pancreatic cancer
A new drug that blocks cancer's escape route from chemotherapy could be used to treat deadly lung and pancreatic cancers, new research reports. Scientists have shown in human cancer cells and in mice that the drug -…





